These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31627378)

  • 1. Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors.
    De Giorgi U; Casadei C; Bergamini A; Attademo L; Cormio G; Lorusso D; Pignata S; Mangili G
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31627378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches for refractory germ cell cancer.
    Oing C; Seidel C; Bokemeyer C
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):389-397. PubMed ID: 29516750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy in germ-cell tumors.
    Droz JP; Culine S; Biron P; Kramar A
    Ann Oncol; 1996 Dec; 7(10):997-1003. PubMed ID: 9037356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors.
    Amato RJ; Prow DM
    Urol Oncol; 2000 Jul; 5(4):134-138. PubMed ID: 10869954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
    Bosl GJ; Yagoda A; Golbey RB; Whitmore W; Herr H; Sogani P; Morse M; Vogelzang N; MacDonald G
    Am J Med; 1985 Mar; 78(3):423-8. PubMed ID: 2983547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors.
    Oing C; Lorch A
    Oncol Res Treat; 2018; 41(6):365-369. PubMed ID: 29843143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.
    Kollmannsberger C; Mayer F; Kuczyk M; Kanz L; Bokemeyer C
    World J Urol; 2001 Apr; 19(2):120-5. PubMed ID: 11374314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
    Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN
    J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
    Broun ER; Nichols CR; Kneebone P; Williams SD; Loehrer PJ; Einhorn LH; Tricot GJ
    Ann Intern Med; 1992 Jul; 117(2):124-8. PubMed ID: 1318648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of advanced testicular cancer.
    Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
    JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
    Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
    J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.
    Oing C; Seidel C; von Amsberg G; Oechsle K; Bokemeyer C
    Expert Opin Pharmacother; 2016; 17(4):545-60. PubMed ID: 26630452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.
    Selle F; Gligorov J; Richard S; Khalil A; Alexandre I; Avenin D; Provent S; Soares DG; Lotz JP
    Braz J Med Biol Res; 2015 Jan; 48(1):13-24. PubMed ID: 25493378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Management of Refractory Germ Cell Tumors and Future Directions.
    Allen JC; Kirschner A; Scarpato KR; Morgans AK
    Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
    Soulié P; Garrino C; Bensmaïne MA; Bekradda M; Brain E; Di Palma M; Goupil A; Misset JL; Cvitkovic E
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):707-11. PubMed ID: 10592105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in ovarian germ cell tumors: A systematic review.
    Simone CG; Markham MJ; Dizon DS
    Gynecol Oncol; 2016 Jun; 141(3):602-607. PubMed ID: 26873864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.